Quebec Pancreas Cancer Study
NCT04104230 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2024-04-17
Summary
The Quebec Pancreas Cancer Study is a prospective clinic-based study consisting of clinical, family history and epidemiologic data, with accompanying biospecimens, from patients diagnosed with either pancreas cancer, a related cancer or a related pre-cancerous condition, and their families.
Conditions
- Pancreas Cancer
- Pancreatic Cancer
- Pancreas Neoplasm
- Pancreas Cyst
- Pancreatic Precancerous Condition
- Familial Pancreatic Cancer
- Hereditary Cancer
- Bile Duct Cancer
- Ampullary Cancer
- Duodenal Cancer
- Gallbladder Cancer
Sponsors & Collaborators
-
George Zogopoulos
lead OTHER
Principal Investigators
-
George Zogopoulos, MD, PhD · McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-12
- Primary Completion
- 2025-01-31
- Completion
- 2025-01-31
Countries
- Canada
Study Locations
More Related Trials
-
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
NCT06151223 ·Status: RECRUITING
-
Province of Ontario Strategy for Personalized Management of Pancreatic Cancer Trial
NCT05927298 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
NCT04473794 ·Status: RECRUITING
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708 ·Status: RECRUITING
-
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
NCT02869802 ·Status: RECRUITING
-
Blood Markers of Early Pancreas Cancer
NCT03568630 ·Status: RECRUITING
-
Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection
NCT02750657 ·Status: COMPLETED
-
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
NCT05262855 ·Status: COMPLETED ·Phase: PHASE2
-
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
NCT01102556 ·Status: RECRUITING
-
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
NCT06271291 ·Status: RECRUITING
-
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
NCT06574620 ·Status: RECRUITING ·Phase: NA
-
A Study of Pancreatic Cancer in Xenografts From Liver Metastases
NCT01774643 ·Status: COMPLETED
-
Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas
NCT06000553 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
NCT05287347 ·Status: WITHDRAWN
-
Pancreas Registry and High Risk Registry
NCT02775461 ·Status: RECRUITING
-
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
NCT05356039 ·Status: RECRUITING
-
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
NCT01335945 ·Status: TERMINATED ·Phase: PHASE1
-
Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
NCT00559598 ·Status: COMPLETED
-
The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
NCT07250100 ·Status: RECRUITING
-
Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC
NCT03032913 ·Status: COMPLETED
-
Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
NCT06349278 ·Status: RECRUITING ·Phase: NA
-
Pancreatic Cancer Early Detection Registry
NCT05519930 ·Status: COMPLETED
-
Biomarkers Study in Pancreatic Cancer
NCT01666184 ·Status: UNKNOWN
-
Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer
NCT03513198 ·Status: UNKNOWN